Skip to search formSkip to main contentSkip to account menu

von Hippel-Lindau peptide vaccine

Known as: VHL Peptides, VHL peptide, VHL peptide vaccine 
A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide… 
National Institutes of Health

Related topics

Related topics

2 relations
Antigen Sensitizationincomplete Freund's adjuvant/interleukin-2/von Hippel-Lindau peptide vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Engrafted VHL peptide-delivered bone marrow stromal cells promote spinal cord repair in rats
Stem cell-based therapy using bone marrow stromal cells (MSCs) has been expected to be a promising therapy for neuronal… 
2004
2004
Vaccine therapy with tumor specific mutated VHL peptides in adult cancer patients with renal cell carcinoma.
2589 Background: Chemotherapy in metastatic renal cell carcinoma is ineffective. Although Interferon α and IL-2 have been used… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)